Thomas Kralj

Creative Research Enterprises (United States)

MedicinePharmacology, Toxicology and PharmaceuticsChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Analytical and Omics-Based Advances in the Study of Drug-Induced Liver Injury”.

Analytical and Omics-Based Advances in the Study of Drug-Induced Liver Injury

Toxicological Sciences(2021)10.1093/toxsci/kfab069

N/A

0DataRank · unranked

40 citations

Kim L. R. Brouwer, Darren J. Creek, Thomas Kralj

Development of an in vitro Metabolic Dysfunction-Associated Steatohepatitis (MASH) model to study hepatic transporters

Drug Metabolism and Pharmacokinetics(2025)10.1016/j.dmpk.2025.101123

N/A

0DataRank · unranked

0 citations

William A. Murphy, Thomas Kralj, John K. Fallon, Jacqueline B. Tiley, Kim L. R. Brouwer +1 more